RxMP Therapeutics, Inc.
PrivateLast Round
Debt
Dec 9, 2025
Total Funding Raised
$11.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RxMP Therapeutics, Inc. is a biotechnology company that develops proprietary hemostatic therapies for the management of hemorrhage and excessive bleeding.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Defense Tech, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxMP Therapeutics, Inc. Comparables
Compare RxMP Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Haima Therapeutics | 88% | |
| Cayuga Biotech | 85% | |
| SelSym Biotech | 84% |
RxMP Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 9, 2025 | ||||
| VC Round | Dec 31, 2021 | ||||
| Accelerator | Jul 30, 2014 |
Key People
Founding team and executive leadership
RxMP Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Wallace H. Coulter Foundation | VC Round, Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
$2M round led by The Wallace H. Coulter Foundation
- Dec 31, 2021
$1.7M round led by The Wallace H. Coulter Foundation.
RxMP Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RxMP Therapeutics, Inc.'s valuation, stock price, and market status.
Is RxMP Therapeutics, Inc. a public or private company?
RxMP Therapeutics, Inc. is a private company.
What is the current stock price of RxMP Therapeutics, Inc.?
RxMP Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is RxMP Therapeutics, Inc. worth (valuation)?
Valuation information for RxMP Therapeutics, Inc. is not publicly available.
Can I buy RxMP Therapeutics, Inc. stock?
RxMP Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RxMP Therapeutics, Inc.'s last funding round?
RxMP Therapeutics, Inc.'s most recent funding round was Debt on December 9, 2025.
Who are the main investors in RxMP Therapeutics, Inc.?
Key investors in RxMP Therapeutics, Inc. include The Wallace H. Coulter Foundation.
Will RxMP Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for RxMP Therapeutics, Inc..
How can I track RxMP Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RxMP Therapeutics, Inc.'s secondary market activity and sign up for updates.